GSK Boostrix Vaccine Class Action Settlement
A class action settlement resolves allegations that GSK made misleading marketing claims about the Boostrix vaccine. If you are a New York resident who received a Boostrix vaccine, you may be entitled to up to $50 — with no proof of vaccination required to file a claim.
Do I Qualify?
You may be eligible if:
- You are a New York resident
- You received a Boostrix vaccine
- You were allegedly misled by GSK's marketing claims
- You submit a valid claim before the deadline listed on the official settlement page
No proof is required. You do not need to provide proof of vaccination to file a claim. Eligible class members may receive up to $50.
Claim filing closed. The deadline was June 8, 2026. Visit the official settlement website for status updates only.
What Happened?
GlaxoSmithKline (GSK), the manufacturer of the Boostrix Tdap vaccine, was sued by New York residents for allegedly making misleading marketing claims about the vaccine. The lawsuit alleged that GSK overstated the vaccine's effectiveness and made claims that were not fully supported by the available clinical evidence in its marketing to New York consumers.
How Much Will I Actually Get?
Eligible New York residents who received a Boostrix vaccine can claim up to $50 with no proof of vaccination required. This settlement is limited to New York residents only. Check the official settlement page for the current deadline and filing instructions.
Last reviewed: June 21, 2026| Information verified from court records and official settlement documents.